Pulmonary function tests
110 results
1 - 100
Imaging for the exclusion of pulmonary embolism in pregnancy- Bronchodilators for bronchiolitis
- Educational interventions for health professionals managing chronic obstructive pulmonary disease in primary care
- Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease
- Heliox for treatment of exacerbations of chronic obstructive pulmonary disease
- Surgical interventions for treating pectus excavatum
- Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis
- Interventions for sexual dysfunction in people with chronic obstructive pulmonary disease (COPD)
- Heliox for non‐intubated acute asthma patients
- Oxygen therapy during exercise training in chronic obstructive pulmonary disease
- Inhaled short‐acting beta2‐agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease
- Respiratory muscle training for multiple sclerosis
- Prostacyclin for pulmonary arterial hypertension
- Non-steroid agents for idiopathic pulmonary fibrosis: Cochrane systematic review
- Inhaled steroids for acute asthma following emergency department discharge
- Pulmonary rehabilitation for chronic obstructive pulmonary disease
- Early use of inhaled corticosteroids in the emergency department treatment of acute asthma: Cochrane systematic review
- Azoles for allergic bronchopulmonary aspergillosis associated with asthma
- Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis
- Newborn screening for cystic fibrosis: Cochrane systematic review
- Thrombolytic therapy for pulmonary embolism
- Corticosteroids for tuberculous pleurisy
- Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis
- Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease
- Dornase alfa for cystic fibrosis
- Exercise training for adult lung transplant recipients
- Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD
- Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI
- Pulmonary rehabilitation versus usual care for adults with asthma
- Continuous versus intermittent beta‐agonists for acute asthma
- Nebulised hypertonic saline for cystic fibrosis
- Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease
- Home care by outreach nursing for chronic obstructive pulmonary disease
- Regular long‐term red blood cell transfusions for managing chronic chest complications in sickle cell disease
- Proton pump inhibitors for chronic obstructive pulmonary disease
- Recombinant growth hormone therapy for cystic fibrosis in children and young adults
- Magnesium sulfate for treating exacerbations of acute asthma in the emergency department
- Preoperative physical therapy for elective cardiac surgery patients
- Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease
- Methylxanthines for exacerbations of chronic obstructive pulmonary disease
- Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease
- Antibiotics for exacerbations of chronic obstructive pulmonary disease
- Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease
- Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long‐term condition: a mixed methods review
- Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD)
- Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease
- Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease
- Stem cell transplantation for systemic sclerosis
- Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome
- Magnesium sulphate for treating acute bronchiolitis in children up to two years of age
- Respiratory muscle training for cystic fibrosis
- Inhaled corticosteroids with combination inhaled long‐acting beta2‐agonists and long‐acting muscarinic antagonists for chronic obstructive pulmonary disease
- Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy
- Short acting beta2‐agonists for recurrent wheeze in children under two years of age
- Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease
- Intravenous beta2‐agonists versus intravenous aminophylline for acute asthma
- Mast‐cell stabilising agents to prevent exercise‐induced bronchoconstriction
- Addition of intravenous beta 2 -agonists to inhaled beta 2 -agonists for acute asthma: Cochrane systematic review
- Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease
- Antibiotic treatment for non‐tuberculous mycobacteria lung infection in people with cystic fibrosis
- Exercise versus airway clearance techniques for people with cystic fibrosis
- Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma
- Insulin and oral agents for managing cystic fibrosis‐related diabetes
- Respiratory muscle training for cervical spinal cord injury: Cochrane systematic review
- Cyclophosphamide for connective tissue disease–associated interstitial lung disease
- Nutritional supplementation for stable chronic obstructive pulmonary disease: Cochrane systematic review
- Inhaled mannitol for cystic fibrosis
- Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease
- Tiotropium versus long‐acting beta‐agonists for stable chronic obstructive pulmonary disease
- Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis
- Nitrous oxide‐based techniques versus nitrous oxide‐free techniques for general anaesthesia
- Tiotropium versus placebo for chronic obstructive pulmonary disease
- Long‐acting inhaled bronchodilators for cystic fibrosis
- Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis
- Haemodilution for acute ischaemic stroke
- Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis
- Digital interventions for the management of chronic obstructive pulmonary disease
- Corticosteroids for preventing relapse following acute exacerbations of asthma: Cochrane systematic review
- Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit
- Vitamin A and beta (β)‐carotene supplementation for cystic fibrosis
- Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma: Cochrane systematic review
- Prophylactic anti‐staphylococcal antibiotics for cystic fibrosis
- Swimming training for asthma in children and adolescents aged 18 years and under
- Automated telephone communication systems for preventive healthcare and management of long‐term conditions
- Inhaled corticosteroids for subacute and chronic cough in adults
- Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children: Cochrane systematic review
- Psychological interventions for individuals with cystic fibrosis and their families
- Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction
- Heliox inhalation therapy for bronchiolitis in infants
- Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)